ACLS AXCELIS TECHNOLOGIES INC
Special Industry Machinery, NEC · Nasdaq · SEC CIK 1113232 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY4.3%
TTM net income YoY-23.1%
TTM EPS YoY-20.8%
Revenue 3-yr CAGR-6.4%
Net income 3-yr CAGR-23.4%
Margins
Gross margin42.8%
Operating margin10.3%
Net margin11.7%
FCF margin6.7%
EBITDA margin12.3%
Returns
ROE9.8%
ROA7.4%
ROIC (approx.)9.8%
Asset turnover0.63x
Leverage & solvency
Liabilities / assets24.7%
Debt / equity0.00x
Current ratio4.43x
Interest coverage15.68x
Cash quality & payout
Operating cash flow / net income0.67x
Accruals ratio2.4%
Payout ratio—
Capex / revenue1.1%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q32026-09-30 | 2026Q22026-06-30 | 2026Q12026-03-31 | 2025Q4*2025-12-31 | 2025Q32025-09-30 | 2025Q22025-06-30 | 2025Q12025-03-31 | 2024Q4*2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $237.78M | $215.18M | $198.96M | $238.33M | $213.61M | $194.54M | $192.56M | $252.42M |
| Cost of revenue | $140.36M | $123.99M | $118.38M | $126.40M | $124.81M | $107.20M | $103.80M | $136.19M |
| Gross profit | $97.42M | $91.19M | $80.58M | $111.93M | $88.81M | $87.34M | $88.77M | $116.22M |
| R&D expense | $30.18M | $28.98M | $28.52M | $30.13M | $24.64M | $27.06M | $27.13M | $27.65M |
| SG&A expense | $23.07M | $22.38M | $26.76M | $26.23M | $23.31M | $16.31M | $17.36M | $17.48M |
| Operating income | $27.34M | $20.28M | $7.95M | $36.17M | $25.02M | $28.96M | $29.16M | $54.53M |
| Interest expense | $1.96M | $1.26M | $1.29M | $1.34M | $1.30M | $1.35M | $1.37M | $1.45M |
| Pretax income | $36.01M | $25.35M | $10.62M | $40.02M | $30.15M | $35.00M | $33.08M | $58.65M |
| Income tax | -$1.75M | $2.06M | $1.41M | $5.72M | $4.16M | $3.62M | $4.50M | $8.69M |
| Net income | $37.76M | $23.29M | $9.21M | $34.30M | $25.99M | $31.38M | $28.58M | $49.96M |
| EBITDA | $31.84M | $24.68M | $12.39M | $40.63M | $29.32M | $33.47M | $33.47M | $58.80M |
| EPS (basic) | 1.22 | 0.76 | 0.30 | — | 0.83 | 0.99 | 0.89 | — |
| EPS (diluted) | 1.21 | 0.75 | 0.30 | — | 0.83 | 0.98 | 0.88 | — |
| Weighted avg. shares (diluted) | 31.11M | 31.13M | 30.98M | — | 31.45M | 31.88M | 32.34M | — |
| Banking | ||||||||
| Provision for credit losses | — | — | — | — | — | $0 | $0 | — |
| Balance sheet | ||||||||
| Cash & equivalents | $190.77M | $155.00M | $150.83M | $145.45M | $195.13M | $181.28M | $191.51M | $131.06M |
| Short-term investments | $281.59M | $247.22M | $215.77M | $228.80M | $262.06M | $376.19M | $403.10M | $447.83M |
| Receivables | $154.71M | $154.15M | $161.81M | $168.48M | $147.64M | $138.84M | $164.95M | $203.15M |
| Inventory | $376.34M | $338.17M | $326.05M | $329.01M | $324.34M | $310.77M | $295.85M | $282.23M |
| Current assets | $1.10B | $979.77M | $935.68M | $943.20M | $984.03M | $1.06B | $1.11B | $1.12B |
| PP&E, net | $59.47M | $58.02M | $57.73M | $56.15M | $57.98M | $57.38M | $57.03M | $53.78M |
| Total assets | $1.48B | $1.39B | $1.37B | $1.36B | $1.35B | $1.32B | $1.34B | $1.35B |
| Current liabilities | $248.40M | $200.10M | $203.91M | $197.66M | $198.99M | $177.11M | $200.37M | $207.52M |
| Total liabilities | $364.28M | $321.02M | $329.90M | $326.67M | $331.80M | $301.10M | $313.38M | $335.99M |
| Shareholders' equity | $1.11B | $1.07B | $1.04B | $1.03B | $1.02B | $1.02B | $1.03B | $1.01B |
| Shares outstanding | 30.88M | 30.88M | 30.73M | 30.72M | 31.00M | 31.42M | 32.13M | 32.37M |
| Cash flow statement | ||||||||
| Operating cash flow | $40.22M | $18.37M | $18.14M | -$6.57M | $45.35M | $39.73M | $39.80M | $12.78M |
| Capital expenditure | $2.50M | $3.55M | $1.84M | $2.33M | $2.02M | $1.99M | $4.96M | $4.66M |
| Free cash flow | $37.72M | $14.82M | $16.30M | -$8.90M | $43.34M | $37.74M | $34.84M | $8.12M |
| Investing cash flow | -$6.15M | -$6.10M | -$10.64M | -$7.31M | $1.38M | -$4.61M | $40.47M | $9.12M |
| Financing cash flow | -$557,000 | -$7.85M | -$1.40M | -$24.62M | -$32.77M | -$46.99M | -$20.11M | -$14.54M |
| Depreciation & amortization | $4.50M | $4.40M | $4.44M | $4.46M | $4.30M | $4.50M | $4.31M | $4.27M |
| Stock-based compensation | $6.50M | $6.40M | $4.90M | $5.11M | $5.30M | $5.40M | $4.90M | $5.38M |
| Share buybacks | $0 | — | — | $25.23M | $32.34M | $45.34M | $18.18M | $15.13M |
Free plan shows the latest 8 periods; Pro shows all 66 🔒
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.